Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China
CONCLUSION: The triple therapy (FF/UMEC/VI) is more affordable than dual therapy (UMEC/VI) when compared to China's three times GDP per capita criterion.PMID:38621548 | DOI:10.1016/j.rmed.2024.107632 (Source: Respiratory Care)
Source: Respiratory Care - April 15, 2024 Category: Respiratory Medicine Authors: Yuan Zhou Shujing Duan Lei Zhang Fangchen Peng Source Type: research
Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China
A study has analyzed the long-term cost-effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol combination therapy (FF/UMEC/VI) versus umeclidinium bromide/vilanterol dual therapy (UMEC/VI) in the treatment of moderate or severe chronic obstructive pulmonary disease (COPD), providing evidence for decision-making in COPD treatment. (Source: Respiratory Medicine)
Source: Respiratory Medicine - April 13, 2024 Category: Respiratory Medicine Authors: Yuan Zhou, Shujing Duan, Lei Zhang, Fangchen Peng Source Type: research
Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
CONCLUSION: Compared with FS, BF therapy appears to be a more promising treatment strategy for patients with moderate-to-severe COPD; however, this should be verified in further high-quality studies.PMID:38573085 | DOI:10.1080/15412555.2024.2328708 (Source: COPD: Journal of Chronic Obstructive Pulmonary Disease)
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - April 4, 2024 Category: Respiratory Medicine Authors: Nan Shang Yang Liu Yueping Jin Source Type: research
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Respir Res. 2024 Apr 1;25(1):152. doi: 10.1186/s12931-024-02745-x.NO ABSTRACTPMID:38561735 | DOI:10.1186/s12931-024-02745-x (Source: Respiratory Care)
Source: Respiratory Care - April 2, 2024 Category: Respiratory Medicine Authors: Afisi S Ismaila Kieran J Rothnie Robert P Wood Victoria L Banks Lucinda J Camidge Alexandrosz Czira Chris Compton Raj Sharma Shannon N Millard Olivia Massey David M G Halpin Source Type: research
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Respir Res. 2024 Apr 1;25(1):152. doi: 10.1186/s12931-024-02745-x.NO ABSTRACTPMID:38561735 | PMC:PMC10983733 | DOI:10.1186/s12931-024-02745-x (Source: Respiratory Care)
Source: Respiratory Care - April 2, 2024 Category: Respiratory Medicine Authors: Afisi S Ismaila Kieran J Rothnie Robert P Wood Victoria L Banks Lucinda J Camidge Alexandrosz Czira Chris Compton Raj Sharma Shannon N Millard Olivia Massey David M G Halpin Source Type: research
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
(Source: Respiratory Research)
Source: Respiratory Research - April 1, 2024 Category: Respiratory Medicine Authors: Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey and David M. G. Halpin Tags: Correction Source Type: research
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults
Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic haematopoietic stem cell transplantation, characterised by a broad disease spectrum that can affect virtually any organ. Although pulmonary cGvHD is a less common manifestation, it is of great concern due to its severity and poor prognosis. Optimal management of patients with pulmonary cGvHD is complicated and no standardised approach is available. The purpose of this joint European Respiratory Society (ERS) and European Society for Blood and Marrow Transplantation task force was to develop evidence-based recommendations regarding the treat...
Source: European Respiratory Journal - March 28, 2024 Category: Respiratory Medicine Authors: Bos, S., Murray, J., Marchetti, M., Cheng, G.-S., Bergeron, A., Wolff, D., Sander, C., Sharma, A., Badawy, S. M., Peric, Z., Piekarska, A., Pidala, J., Raj, K., Penack, O., Kulkarni, S., Beestrum, M., Linke, A., Rutter, M., Coleman, C., Tonia, T., Schoema Tags: Respiratory clinical practice Original Articles: ERS/EBMT guidelines Source Type: research
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids
CONCLUSION: In a real-world clinical setting where there may be poor adherence to prescribed therapy, our findings suggest a significant therapeutic advantage for longer-acting ICS molecules in patients with asthma.PMID:38532238 | DOI:10.1007/s12325-024-02823-y (Source: Adv Data)
Source: Adv Data - March 27, 2024 Category: Epidemiology Authors: Peter T Daley-Yates Bhumika Aggarwal Maximilian Plank Source Type: research
Efficacy and Safety of Once-Daily Vilanterol/Fluticasone Furoate MDI in Persistent Asthma: Phase 3 OD-INHALE study
Conclusion: Once daily VI/FF pMDI was non-inferior to twice daily FOR/FP pMDI in patients with persistent asthma.PMID:38488853 | DOI:10.1080/02770903.2024.2330485 (Source: Journal of Asthma)
Source: Journal of Asthma - March 15, 2024 Category: Respiratory Medicine Authors: Avdhesh Kumar Manish Kumar Jain Vijaykumar Bhagwan Barge Raghumanda Sunil Kumar Neeraj Gupta Harendra Yadav Amitava Pal Vivek Eknath Redkar Asish Mondal Rahul Kumar Rathore Pavankumar Daultani Ashok Jaiswal Ravi T Mehta Source Type: research
